Protocol summary

Study aim
Primary objective is to assess whether 2 g IV magnesium sulfate reduces hypoxia during OLV in thoracotomy. Secondary objectives include evaluating severity and duration of hypoxia, hemodynamic and EtCO₂ changes, and adverse events.
Design
A randomized, double‑blind
Settings and conduct
Patients are randomly assigned using sealed envelopes. Study conducted at a university thoracic surgery center.
Participants/Inclusion and exclusion criteria
Inclusion: adults 18–65 undergoing elective thoracotomy with OLV. Exclusion: pregnancy, magnesium allergy, severe cardiac/renal failure.
Intervention groups
Intervention group receives 2 g magnesium sulfate IV after induction; control receives equal volume of normal saline.
Main outcome variables
Primary outcome is incidence of hypoxia (SpO₂ < 90%); secondary outcomes include hemodynamic and EtCO₂ changes.

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20250923067343N4
Registration date: 2026-06-05, 1405/03/15
Registration timing: prospective

Last update: 2026-06-05, 1405/03/15
Update count: 0
Registration date
2026-06-05, 1405/03/15
Registrant information
Name
kobra Rafiei badi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 2269 0414
Email address
abrisham57@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2026-06-22, 1405/04/01
Expected recruitment end date
2026-09-22, 1405/06/31
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Effect of Intravenous Magnesium Sulfate Administration on Reducing Intraoperative Hypoxia in Patients Undergoing Thoracotomy
Public title
Effect of Magnesium Sulfate on Reducing Oxygen Desaturation During Chest Surgery.
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
informed consent Age 18 to 65 years ASA class I–III Candidate for elective thoracotomy Requirement for one‑lung ventilation (OLV).
Exclusion criteria:
Severe cardiac or renal failure History of magnesium hypersensitivity Pregnancy Intraoperative termination of surgery or inability to continue OLV due to unexpected causes Need for urgent change in the anesthesia technique
Age
From 18 years old to 70 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Care provider
  • Investigator
  • Outcome assessor
  • Data analyser
Sample size
Target sample size: 70
Randomization (investigator's opinion)
Randomized
Randomization description
Method: Block randomization with blocks of four Allocation ratio: 1:1 Software: Random Allocation Software Allocation concealment: Sequentially numbered, opaque, sealed envelopes (SNOSE)
Blinding (investigator's opinion)
Double blinded
Blinding description
This study is designed as a double-blind clinical trial. To maintain blinding, the intervention solution (magnesium sulfate) and the placebo (normal saline) will be prepared by a third party (pharmacist or research nurse) in syringes identical in appearance, volume, and color. All solutions will be administered at the same rate and timing. Group allocation will be performed using a computer-generated random sequence with proper allocation concealment. Throughout the study, the patients, anesthesiologists, surgical team, and outcome assessors will remain unaware of the assigned intervention in order to minimize the risk of bias.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Shahid Beheshti University of Medical Sciences
Street address
5th Floor, Building No. 2, Shahid Arabi St., Yaman St., Shahid Chamran Hwy., Tehran, Iran.
City
Tehran
Province
Tehran
Postal code
1314744513
Approval date
2026-05-23, 1405/03/02
Ethics committee reference number
IR.SBMU.MSP.REC.1405.123

Health conditions studied

1

Description of health condition studied
The patient undergoing thoracotomy surgery.
ICD-10 code
G54.3
ICD-10 code description
Thoracic root disorders, not elsewhere classified

Primary outcomes

1

Description
Incidence of hypoxia (SpO₂ < 90% ≥ 30 s)
Timepoint
Throughout OLV
Method of measurement
Pulse oximetry

Secondary outcomes

1

Description
Mean SpO₂
Timepoint
Baseline, 15 min OLV, 30 min OLV
Method of measurement
Pulse oximetry

2

Description
mean Etco2
Timepoint
Cnotinuous
Method of measurement
Capnography

3

Description
ContinuousMAP and HR
Timepoint
every 5 minutes
Method of measurement
Standard monitoring

4

Description
Number of hypoxic episodes
Timepoint
During OLV
Method of measurement
Continuous monitoring

Intervention groups

1

Description
In the intervention group, 2 g of intravenous magnesium sulfate diluted in 100 mL of normal saline is administered immediately after anesthesia induction over 15–20 minutes.
Category
Treatment - Drugs

2

Description
Control group: In the control group, 100 mL of normal saline is administered intravenously immediately after anesthesia induction over 15–20 minutes. The appearance, volume, and method of administration are identical to the intervention group to maintain blinding.
Category
Treatment - Devices

Recruitment centers

1

Recruitment center
Name of recruitment center
Masih Daneshvari Hospital
Full name of responsible person
Kobra Rafiei Badi
Street address
Masih Daneshvari Hospital, Imam Hassan Building, 10th Floor, Department of Anesthesiology, Darabad, Shahid Bahonar Street, Tehran, Iran
City
Tehran
Province
Tehran
Postal code
1956944413
Phone
+98 21 2712 3888
Email
abrisham57@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Afshin Zarghi
Street address
5th Floor, Building No. 2, Shahid Arabi St., Yaman St., Shahid Chamran Hwy., Tehran, Iran
City
Tehran
Province
Tehran
Postal code
1314744513
Phone
+98 21 2243 9780
Email
info@sbmu.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Shahid Beheshti University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Kobra Rafiei Badi
Position
assistant of professor
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Department of Anesthesiology, Imam Hassan Building, Masih Daneshvari Hospital, Shahid Bahonar Street, Darabad, Tehran, Iran.
City
Tehran
Province
Tehran
Postal code
1945694413
Phone
+98 21 2712 3888
Email
abrisham57@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Kobra Rafiei Badi
Position
Assistant of Professor
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Masih Daneshvari Hospital, Imam Hassan Building, 10th Floor, Department of Anesthesiology, Darabad, Shahid Bahonar Street, Tehran, Iran
City
Tehran
Province
Tehran
Postal code
1956944413
Phone
+98 21 2712 3888
Email
abrisham57@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Kobra Rafiei Badi
Position
assistant professor
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Masih Daneshvari Hospital, Imam Hassan Building, 10th Floor, Department of Anesthesiology, Darabad, Shahid Bahonar Street, Tehran, Iran
City
Tehran
Province
Tehran
Postal code
1956944413
Phone
0982127123888
Email
abrisham57@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
No - There is not a plan to make this available
Statistical Analysis Plan
No - There is not a plan to make this available
Informed Consent Form
No - There is not a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Not applicable
Loading...